These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1902 related articles for article (PubMed ID: 7907615)

  • 41. Malignant melanoma of the ear.
    Davidsson A; Hellquist HB; Villman K; Westman G
    J Laryngol Otol; 1993 Sep; 107(9):798-802. PubMed ID: 7901312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of proliferating cell nuclear antigen (PCNA): proliferative phase functions and malignant transformation of melanocytes.
    Iyengar B
    Melanoma Res; 1994 Oct; 4(5):293-5. PubMed ID: 7858412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
    Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
    Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.
    Kirkegaard LJ; DeRose PB; Yao B; Cohen C
    Am J Clin Pathol; 1998 Jan; 109(1):69-74. PubMed ID: 9426520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of proliferating cell nuclear antigen (PCNA) in squamous cell carcinoma of the esophagus.
    Kinugasa S; Tachibana M; Hishikawa Y; Abe S; Yoshimura H; Monden N; Dhar DK; Nagasue N
    Jpn J Clin Oncol; 1996 Dec; 26(6):405-10. PubMed ID: 9001344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome.
    Amin MB; Ma CK; Linden MD; Kubus JJ; Zarbo RJ
    Am J Clin Pathol; 1993 Oct; 100(4):428-32. PubMed ID: 8105676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.
    Klemi PJ; Alanen K; Jalkanen S; Joensuu H
    Br J Cancer; 1992 Oct; 66(4):739-43. PubMed ID: 1358164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GSTO1 regards as a meritorious regulator in cutaneous malignant melanoma cells.
    Wang LK; Yue HL; Peng XJ; Zhang SJ
    Mol Cell Probes; 2019 Dec; 48():101449. PubMed ID: 31525447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proliferating cell nuclear antigen expression in normal, regenerative, and neoplastic liver: a fine-needle aspiration cytology and biopsy study.
    Ojanguren I; Ariza A; Llatjós M; Castellà E; Mate JL; Navas-Palacios JJ
    Hum Pathol; 1993 Aug; 24(8):905-8. PubMed ID: 7690737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical staining of proliferating cell nuclear antigen (PCNA) in malignant and nonmalignant skin diseases.
    Kawahira K
    Arch Dermatol Res; 1999; 291(7-8):413-8. PubMed ID: 10482011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
    Lipponen PK; Eskelinen MJ
    Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Expression of squamous cell carcinoma-associated antigen in bladder cancer cells--a comparative study with the expression of proliferating cell nuclear antigen (PCNA)].
    Yamazaki K; Kumamoto Y; Tsukamoto T
    Nihon Hinyokika Gakkai Zasshi; 1994 Apr; 85(4):589-98. PubMed ID: 7910645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
    Karbowniczek M; Chosia M; Domagała W
    Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitotic indices, anti-PCNA immunostaining, and AgNORs in thick cutaneous melanomas displaying paradoxical behaviour.
    Evans AT; Blessing K; Orrell JM; Grant A
    J Pathol; 1992 Sep; 168(1):15-22. PubMed ID: 1360495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions].
    Sawada M; Ueda G; Inoue M; Shimizu H; Ogawa H; Nakazawa A; Fujita M; Tanizawa O; Tsujimoto M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell proliferation markers in predicting metastases in malignant melanoma.
    Reddy VB; Gattuso P; Aranha G; Carson HJ
    J Cutan Pathol; 1995 Jun; 22(3):248-51. PubMed ID: 7593819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proliferative activity in the malignant cellular blue nevus.
    Pich A; Chiusa L; Margaria E; Aloi F
    Hum Pathol; 1993 Dec; 24(12):1323-9. PubMed ID: 7903955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The evaluation of cellular proliferating activity in gastric carcinoma with the proliferating cell nuclear antigen (PCNA) expressive rate: its fundamental examination of the immunohistochemical procedures and its clinical applications].
    Nakano H; Namatame K; Nakayoshi A; Kumada K
    Nihon Geka Gakkai Zasshi; 1993 Jun; 94(6):580-92. PubMed ID: 8101959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas.
    Mikou P; Kanavaros P; Aninos D; Tzardi M; Karameris A; Gorgoulis B; Papadopoulos N; Lavergne A; Galian A
    Pathol Res Pract; 1993 Nov; 189(9):1004-9. PubMed ID: 7905623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups.
    Pe'er J; Gnessin H; Shargal Y; Livni N
    Ophthalmology; 1994 Jan; 101(1):56-62. PubMed ID: 7905616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 96.